EUVIMEDEUVIMED entdecken
Crossref

Exploiting Tumor Cell Invasiveness to Construct an Isolated Niche for Postoperative Immunotherapy

Yuxi Cheng iD, Bo Pang iD, Qian Wu, Chang Yang, Rongbing Tang iD

Advanced Materials · 2026-11 · 38 (62)

DOI: 10.1002/adma.75102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 24.09.2026. Verfasst von Yuxi Cheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Stomatology, Lanzhou University, Lanzhou, P. R. China. Hauptthemen laut MEDLINE: Immunotherapy. Die Arbeit nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Gansu Provincial Youth Talent Project, Gansu Association for Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Residual tumor cells persisting in the surgical bed are the principal drivers of postoperative tumor recurrence, yet the immunosuppressive wound healing microenvironment limits immune activation and compromises antigen enrichment and cross‐presentation. To address this issue, we exploited tumor cell invasiveness to construct isolated niches that confine the cells in micron‐scale chambers shielded from external microenvironmental perturbations. For proof of principle, we fabricated a hyaluronic acid‐based double‐network hydrogel comprising HAMA and PEGDA. Hyaluronidase‐dependent invasive tumor cells degrade the hydrogel to form isolated niches and are physically confined. The hydrogel releases DOX/LDH‐engineered Escherichia coli minicells that accumulate in niches, eradicating trapped tumor cells via high local DOX concentrations. Spatial confinement enriches tumor antigens and excludes normal tissue proteins, improving LDH‐mediated antigen capture. Minicells then deliver antigens to dendritic cells; post‐phagocytosis, LDH releases antigens, and Mn 2 + activates the cGAS‐STING pathway, synergistically boosting immune activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyHumansHyaluronic AcidDoxorubicinHydrogelsNeoplasm InvasivenessCell Line, TumorEscherichia coliAnimalsDendritic CellsHyaluronoglucosaminidaseTumor MicroenvironmentAntigens, NeoplasmcGAS-STING Signaling PathwayPolyethylene GlycolsL-Lactate Dehydrogenase

Stichwörter der Autor:innen

STING activationantigen deliverypost‐surgical treatmenttumor vaccine

Substanzen

Hyaluronic AcidDoxorubicinHydrogelsHyaluronoglucosaminidaseAntigens, NeoplasmPolyethylene GlycolsL-Lactate Dehydrogenase

Autor:innen und Institutionen

  • School of Stomatology, Lanzhou University, Lanzhou, P. R. China.
  • Key Laboratory of Dental Maxillofacial Reconstruction and Biological Intelligence Manufacturing, Lanzhou University, Lanzhou, P.R. China.

ORCID-Profile: Yuxi Cheng, Bo Pang, Rongbing Tang

Förderung

  • National Natural Science Foundation of China
  • Gansu Provincial Youth Talent Project
  • Gansu Association for Science and Technology
  • Natural Science Foundation of Gansu Province of China
  • Fundamental Research Funds for the Central Universities
  • Education Technology Innovation Project of Gansu Province
  • Lanzhou Municipal Science and Technology Plan Project

Zitieren

APA

Cheng, Y., Pang, B., Wu, Q., Yang, C., & Tang, R. (2026). Exploiting Tumor Cell Invasiveness to Construct an Isolated Niche for Postoperative Immunotherapy. Advanced Materials, 38(62). https://doi.org/10.1002/adma.75102

Vancouver

Cheng Y, Pang B, Wu Q, Yang C, Tang R. Exploiting Tumor Cell Invasiveness to Construct an Isolated Niche for Postoperative Immunotherapy. Advanced Materials. 2026;38(62). doi:10.1002/adma.75102

BibTeX
@article{Cheng2026,
  author = {Cheng, Yuxi and Pang, Bo and Wu, Qian and Yang, Chang and Tang, Rongbing},
  title = {Exploiting Tumor Cell Invasiveness to Construct an Isolated Niche for Postoperative Immunotherapy},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {62},
  doi = {10.1002/adma.75102}
}
Kostenlos starten →